Market Analysis and Insights: Global Immunofluorescence Assays Market
Immunofluorescence is the specific antigen and antibody reaction where the antibodies are labeled with a fluorescent dye and the antigen-antibody complex is visualized using fluorescent (UV) microscope. Some of the commonly used fluorochromes include Acridine Orange, Lissamine, Rhodamine, and Calcofluor white. Various factors determine the type of immunofluorescence assay used such as time consumed, cost, complexity, flexibility, sensitivity, cross reactivity and many others. It is used in all disciplines of biology including medicine for diagnostics and research. Immunofluorescence assays are used to detect specific proteins in cells that may be in specimen, in culture, in tissues, on microbeads and microarrays, etc.
The global Immunofluorescence Assays market size is projected to reach US$ 2196.9 million by 2028, from US$ 1678.4 million in 2021, at a CAGR of 3.9% during 2022-2028.
Fully considering the economic change by this health crisis, Antibodies accounting for % of the Immunofluorescence Assays global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Clinical Research segment is altered to an % CAGR throughout this forecast period.
China Immunofluorescence Assays market size is valued at US$ million in 2021, while the North America and Europe Immunofluorescence Assays are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Immunofluorescence Assays landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immunofluorescence Assays market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immunofluorescence Assays market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immunofluorescence Assays market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immunofluorescence Assays market.
Global Immunofluorescence Assays Scope and Market Size
Immunofluorescence Assays market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Immunofluorescence Assays market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Antibodies
Kits and Reagents
Labeling Dyes
Segment by Application
Clinical Research
Laboratory Diagnostics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Thermo Fisher
Inova Diagnostics
Bio-Rad
Abcam
PerkinELmer
Merck Millipore
Cell Signaling Technology
MEDIPAN GMBH
Sino Biological
Danaher
Vector Laboratories